Zoetis Return on Equity

Zoetis (ZOE.DE) currently reports a ROE of 83.1%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Zoetis's ROE history and peer comparisons.

Zoetis's ROE of 83.1% is higher than the Healthcare sector average of -75.84%. That is roughly 209.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Zoetis's current 83.1% should be judged against Healthcare norms (sector average: -75.84%) and against ZOE.DE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 83.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Zoetis, and consider following ZOE.DE for alerts when major investors trade the stock.

Zoetis is classified in the Healthcare sector. On ROE, it currently shows 83.1% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZOE.DE with unrelated industries.